| # |
Company Name
|
Industry Name
|
Latest Price (Rs.)
|
Price Change
Rs (%) |
Market Cap
|
Net Sales
(Rs. Cr.) |
Latest EPS
(Rs.) |
Net Profit
Margin % |
Latest
P/E |
Latest
P/BV |
|---|---|---|---|---|---|---|---|---|---|---|
| Alembic Pharma | Pharmaceuticals& Drugs | 728.4 |
9.2 (1.28%) |
Small Cap | 6,672 | 32 | 8.29 | 22.5 | 2.6 | |
| Piramal Pharma | Pharmaceuticals& Drugs | 149.5 |
3 (2.05%) |
Small Cap | 5,286 | 5.4 | 13.11 | 27.2 | 2.5 | |
| Ajanta Pharma | Pharmaceuticals& Drugs | 2,902.9 |
7.05 (0.24%) |
Small Cap | 4,648 | 81.2 | 19.35 | 35.7 | 7.9 | |
| Natco Pharma | Pharmaceuticals& Drugs | 1,083.1 |
6.45 (0.6%) |
Small Cap | 4,430 | 86.9 | 40.5 | 12.4 | 2.2 | |
| Emcure Pharma | Pharmaceuticals& Drugs | 1,643.1 |
12.95 (0.79%) |
Small Cap | 4,382 | 33.7 | 6.24 | 48.4 | 8.9 | |
| Aster DM Healthcare | Hospital &HealthcareServices | 682.2 |
16.35 (2.46%) |
Small Cap | 4,138 | 6.3 | 8.01 | 105.5 | 7.5 | |
| Gland Pharma | Pharmaceuticals& Drugs | 1,769.9 |
48.15 (2.8%) |
Small Cap | 4,116 | 71 | 26.26 | 24.3 | 2.7 | |
| JB Chem & Pharma | Pharmaceuticals& Drugs | 2,009.8 |
11.1 (0.56%) |
Small Cap | 3,723 | 45.3 | 16.97 | 44.1 | 8.2 | |
| Global Health | Hospital &HealthcareServices | 1,084 |
23 (2.17%) |
Small Cap | 3,204 | 17.3 | 15.48 | 61.3 | 7.4 | |
| Granules India | Pharmaceuticals& Drugs | 639.1 |
6.35 (1%) |
Small Cap | 3,030 | 16 | 9.87 | 39.6 | 4 | |
| Wockhardt | Pharmaceuticals& Drugs | 1,354.5 |
-7.65 (-0.56%) |
Small Cap | 3,012 | 1.4 | -1.8 | 1,006.1 | 4.8 | |
| Eris Lifesciences | Pharmaceuticals& Drugs | 1,442.7 |
54.65 (3.94%) |
Small Cap | 2,894 | 31.2 | 12.9 | 44.5 | 5.3 | |
| Dishman Carbogen Amc | Pharmaceuticals& Drugs | 166 |
6.5 (4.08%) |
Small Cap | 2,712 | 7.6 | 0.85 | 21.1 | 0.4 | |
| Aarti Drugs | Pharmaceuticals& Drugs | 359.5 |
6.5 (1.84%) |
Small Cap | 2,387 | 22.2 | 7.04 | 15.9 | 2.1 | |
| Alivus Life Sciences | Pharmaceuticals& Drugs | 1,057.8 |
11.3 (1.08%) |
Small Cap | 2,387 | 44.3 | 20.07 | 23.6 | 4.1 | |
| Dr. Lal Pathlabs | Hospital &HealthcareServices | 1,420.7 |
40.1 (2.9%) |
Small Cap | 2,352 | 30.8 | 21.21 | 44.9 | 9.2 | |
| Pfizer | Pharmaceuticals& Drugs | 4,917 |
67.2 (1.39%) |
Small Cap | 2,281 | 186.6 | 28.39 | 26 | 5.6 | |
| Strides Pharma Scien | Pharmaceuticals& Drugs | 1,002.7 |
0.95 (0.09%) |
Small Cap | 2,139 | 19.9 | 2.46 | 50.3 | 2.8 | |
| IOL Chem & Pharma | Pharmaceuticals& Drugs | 84.1 |
0.59 (0.71%) |
Small Cap | 2,079 | 4 | 4.59 | 21.2 | 1.4 | |
| FDC | Pharmaceuticals& Drugs | 358.1 |
5.85 (1.66%) |
Small Cap | 2,070 | 14 | 12.16 | 25.3 | 2.3 | |
| Caplin Point Lab | Pharmaceuticals& Drugs | 1,704.4 |
18.15 (1.08%) |
Small Cap | 1,937 | 80.7 | 27.17 | 20.9 | 3.9 | |
| Hikal | Pharmaceuticals& Drugs | 186.4 |
3.3 (1.8%) |
Small Cap | 1,860 | -1.1 | 4.72 | - | 1.9 | |
| Sanofi India | Pharmaceuticals& Drugs | 3,500.3 |
34.75 (1%) |
Small Cap | 1,837 | 141.9 | 18.75 | 24.4 | 11.8 | |
| Aarti Pharmalabs | Pharmaceuticals& Drugs | 710 |
16.25 (2.34%) |
Small Cap | 1,771 | 23.7 | 14.41 | 29.3 | 3.2 | |
| Unichem Lab | Pharmaceuticals& Drugs | 343.2 |
6.1 (1.81%) |
Small Cap | 1,736 | 32 | 8.09 | 10.5 | 0.9 |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: